EMPAGLIFLOZIN IS MORE EFFECTIVE IN REDUCING MICROALBUMINURIA AND ALT LEVELS COMPARED WITH DAPAGLIFLOZIN: REAL LIFE EXPERIENCE


Gunhan H. G. , Imre E., Erel P., Ustay O.

ACTA ENDOCRINOLOGICA-BUCHAREST, cilt.16, sa.1, ss.59-67, 2020 (SCI İndekslerine Giren Dergi) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Konu: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.4183/aeb.2020.59
  • Dergi Adı: ACTA ENDOCRINOLOGICA-BUCHAREST
  • Sayfa Sayıları: ss.59-67

Özet

Context. Sodium Glucose Co-Transporter-2 inhibitors (SGLT2i) are oral antidiabetic agents that can be used with insulin in the treatment of type 2 diabetes mellitus, known for cardiovascular and renal benefits. Dapagliflozin and empagliflozin are available in Turkey and we aimed to evaluate real-life data of using these two molecules with other oral antidiabetic drugs (OAD) or insulin.